- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00546208
Unilateral Cutaneous Ureterostomy - Long Term Follow up (ureterostomy)
March 13, 2008 updated by: Sheba Medical Center
Bladder Function Following Temporary Unilateral Cutaneous Ureterostomy - Long Term Follow up
This observational study is aimed at exploring bladder function following temporary unilateral low loop cutaneous ureterostomy carried out in newborns suffering from severe congenital hydro-ureteronephrosis
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dorit E Zilberman, MD
- Phone Number: +97235302231
- Email: dorit.zilberman@sheba.health.gov.il
Study Locations
-
-
-
Ramat Gan, Israel, 52621
- Recruiting
- The Chaim Sheba medical center, Tel Hashomer
-
Contact:
- Dorit E Zilberman, MD
- Phone Number: +973-3-5302231
- Email: dorit.zilberman@sheba.health.gov.il
-
Sub-Investigator:
- Yoram Mor, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
adolescents and adults who had been operated in our institution for severe bilateral congenital hydro-ureteronephrosis
Description
Inclusion Criteria:
- Living patients
- Bilateral functioning kidneys
- Unilateral ureteral cutaneous diversion
Exclusion Criteria:
- Dead patients
- Single kidney
- High percutaneous ureteral diversion (e.g: cutaneous pyelostomies, bilateral cutaneous urinary diversion)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
1
adolescents and young adults who underwent, as newborns, unilateral low loop cutaneous ureterostomy for severe bilateral hydro-ureteronephrosis, and that, afterwards, underwent stomal closure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dorit E Zilberman, MD, The Chaim Sheba Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2008
Study Registration Dates
First Submitted
October 17, 2007
First Submitted That Met QC Criteria
October 17, 2007
First Posted (Estimate)
October 18, 2007
Study Record Updates
Last Update Posted (Estimate)
March 17, 2008
Last Update Submitted That Met QC Criteria
March 13, 2008
Last Verified
March 1, 2008
More Information
Terms related to this study
Other Study ID Numbers
- SHEBA-07-4838-DZ-CTIL
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bladder Function
-
The University of Texas Health Science Center,...RecruitingBladder Function | Bladder Integrity | Ureteral Integrity | Ureteral FunctionUnited States
-
Astellas Pharma IncTerminatedBladder FunctionUnited States
-
RenJi HospitalCompletedCirculatory Function | Laparoscopic Radical Cystectomy for Bladder CancerChina
-
University of North Carolina, Chapel HillAmerican Urogynecologic SocietyCompletedUrinary Bladder, Overactive | Cognitive Function | Mental CompetencyUnited States
-
APOGEPHA Arzneimittel GmbHCompletedUrologic Diseases | Urinary Incontinence | Urinary Bladder, Neurogenic | Neurogenic Urinary Bladder Disorder | Bladder Disorder, Neurogenic | Urinary Bladder Disorder, Neurogenic | Neurogenic Bladder Disorder | Urinary Bladder Neurogenic Dysfunction | Overactive Detrusor FunctionRomania, Austria, Germany
-
Janssen-Cilag Ltd.,ThailandTerminatedDetrusor Function, OveractiveThailand
-
Tel-Aviv Sourasky Medical CenterUnknownProteinuria | Renal Function | Classic Bladder Exstrophy | GFRIsrael
-
Astellas Pharma IncGlaxoSmithKlineCompleted
-
Chang Gung Memorial HospitalCompletedUrinary Bladder, Overactive | Sexual Behavior | Sexual Function Disturbances | Behavior Therapy | Sexual ActivityTaiwan
-
Mansoura UniversityActive, not recruitingRenal Function Disorder | Pediatric Disorder | Hydronephrosis, Secondary | Hydronephrosis in Children | Hydronephrosis Congenital | Bladder-Neck; Obstruction, Congenital | Urethral ValveEgypt